Enzene Biosciences Ltd.
Clinical trials sponsored by Enzene Biosciences Ltd., explained in plain language.
-
New osteoporosis drug shows promise in Head-to-Head trial
Disease control CompletedThis study tested a new drug called Enzene denosumab (ENZ215) against the approved drug Prolia in 504 postmenopausal women with osteoporosis. The goal was to see if the new drug works as well at increasing bone density and reducing bone breakdown over 12 months. Both drugs are gi…
Phase: PHASE3 • Sponsor: Enzene Biosciences Ltd. • Aim: Disease control
Last updated May 26, 2026 09:56 UTC
-
Healthy men test new bone drug copycat
Knowledge-focused CompletedThis study tested whether a new version of the drug denosumab (called ENZ215) works the same as two already-approved versions (Prolia from Europe and the US). A total of 207 healthy adult male volunteers received a single injection. The goal was to compare how the drug moves thro…
Phase: PHASE1 • Sponsor: Enzene Biosciences Ltd. • Aim: Knowledge-focused
Last updated May 18, 2026 12:02 UTC